Sphera Funds Management as of Dec. 31, 2018
Portfolio Holdings for Sphera Funds Management
Sphera Funds Management holds 98 positions in its portfolio as reported in the December 2018 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| SPDR S&P Biotech (XBI) | 22.2 | $197M | 2.7M | 71.75 | |
| Mylan Nv | 5.2 | $46M | 1.7M | 27.40 | |
| Merck & Co (MRK) | 4.1 | $36M | 472k | 76.41 | |
| Bristol Myers Squibb (BMY) | 3.7 | $33M | 630k | 51.98 | |
| Celgene Corporation | 3.4 | $30M | 465k | 64.09 | |
| Caesar Stone Sdot Yam (CSTE) | 2.7 | $24M | 469k | 50.75 | |
| Verint Systems (VRNT) | 2.7 | $24M | 149k | 158.10 | |
| Amicus Therapeutics (FOLD) | 2.6 | $24M | 2.4M | 9.58 | |
| Gilead Sciences (GILD) | 2.5 | $22M | 350k | 62.55 | |
| AstraZeneca (AZN) | 2.2 | $20M | 515k | 37.98 | |
| Microsoft Corporation (MSFT) | 2.0 | $18M | 47k | 379.55 | |
| Palo Alto Networks (PANW) | 2.0 | $18M | 25k | 703.80 | |
| Alexion Pharmaceuticals | 1.8 | $16M | 168k | 97.36 | |
| Ituran Location And Control (ITRN) | 1.6 | $15M | 122k | 119.80 | |
| Bluebird Bio (BLUE) | 1.6 | $14M | 139k | 99.20 | |
| Allot Communications (ALLT) | 1.5 | $14M | 596k | 22.68 | |
| Sarepta Therapeutics (SRPT) | 1.4 | $13M | 117k | 109.13 | |
| Reata Pharmaceuticals Inc Cl A | 1.4 | $12M | 221k | 56.10 | |
| Sage Therapeutics (SAGE) | 1.4 | $12M | 128k | 95.80 | |
| GlaxoSmithKline | 1.3 | $12M | 310k | 38.21 | |
| Ptc Therapeutics I (PTCT) | 1.3 | $12M | 346k | 34.32 | |
| Teva Pharmaceutical Industries (TEVA) | 1.2 | $11M | 705k | 15.42 | |
| Aldeyra Therapeutics (ALDX) | 1.1 | $10M | 1.2M | 8.30 | |
| Immunomedics | 1.1 | $10M | 707k | 14.27 | |
| Mellanox Technologies | 1.1 | $9.8M | 28k | 345.21 | |
| Argenx Se (ARGX) | 0.9 | $8.4M | 87k | 96.07 | |
| Axovant Sciences | 0.9 | $8.2M | 8.2M | 1.00 | |
| Gw Pharmaceuticals Plc ads | 0.8 | $7.5M | 77k | 97.39 | |
| Cellectis S A (CLLS) | 0.8 | $7.5M | 448k | 16.65 | |
| Retrophin | 0.8 | $7.4M | 326k | 22.63 | |
| Osmotica Pharmaceuticals (RVLPQ) | 0.8 | $7.1M | 922k | 7.75 | |
| Uniqure Nv (QURE) | 0.8 | $6.7M | 233k | 28.82 | |
| Autolus Therapeutics Plc spon ads (AUTL) | 0.8 | $6.7M | 203k | 32.84 | |
| Global Blood Therapeutics In | 0.7 | $6.0M | 147k | 41.05 | |
| Orchard Therapeutics Plc ads | 0.7 | $5.8M | 370k | 15.73 | |
| Forescout Technologies | 0.7 | $5.7M | 59k | 97.11 | |
| Gilat Satellite Networks (GILT) | 0.6 | $5.7M | 167k | 34.23 | |
| Viking Therapeutics (VKTX) | 0.6 | $5.7M | 746k | 7.65 | |
| ArQule | 0.6 | $5.6M | 2.0M | 2.77 | |
| Proqr Thrapeutics N V shs euro (PRQR) | 0.6 | $5.4M | 340k | 15.78 | |
| Minerva Neurosciences | 0.6 | $5.3M | 782k | 6.74 | |
| Biohaven Pharmaceutical Holding | 0.6 | $4.9M | 133k | 36.98 | |
| Mohawk Industries (MHK) | 0.5 | $4.7M | 11k | 437.01 | |
| Epizyme | 0.5 | $4.6M | 750k | 6.16 | |
| Aeglea Biotherapeutics | 0.5 | $4.5M | 600k | 7.49 | |
| Logicbio Therapeutics | 0.5 | $4.3M | 418k | 10.40 | |
| Rocket Pharmaceuticals (RCKT) | 0.5 | $4.3M | 290k | 14.82 | |
| Strongbridge Bioph shs usd | 0.5 | $4.2M | 932k | 4.48 | |
| Cytomx Therapeutics (CTMX) | 0.5 | $4.1M | 273k | 15.10 | |
| Cara Therapeutics (CARA) | 0.5 | $4.0M | 304k | 13.00 | |
| Scholar Rock Hldg Corp (SRRK) | 0.5 | $4.0M | 176k | 22.97 | |
| Sangamo Biosciences (SGMO) | 0.4 | $3.9M | 340k | 11.48 | |
| Ascendis Pharma A S (ASND) | 0.4 | $3.7M | 58k | 62.65 | |
| Neos Therapeutics | 0.4 | $3.6M | 2.2M | 1.65 | |
| Krystal Biotech (KRYS) | 0.4 | $3.6M | 175k | 20.78 | |
| Homology Medicines | 0.4 | $3.6M | 161k | 22.36 | |
| Sutro Biopharma (STRO) | 0.4 | $3.7M | 408k | 9.02 | |
| Evoke Pharma | 0.4 | $3.5M | 1.4M | 2.48 | |
| Arvinas Ord (ARVN) | 0.4 | $3.5M | 271k | 12.85 | |
| Agios Pharmaceuticals (AGIO) | 0.3 | $3.1M | 68k | 46.10 | |
| Kadmon Hldgs | 0.3 | $3.1M | 1.5M | 2.08 | |
| Allogene Therapeutics (ALLO) | 0.3 | $3.1M | 113k | 26.93 | |
| Ac Immune Sa (ACIU) | 0.3 | $2.9M | 311k | 9.45 | |
| Portola Pharmaceuticals | 0.3 | $2.9M | 147k | 19.52 | |
| Xenon Pharmaceuticals (XENE) | 0.3 | $2.8M | 450k | 6.31 | |
| Glycomimetics (GLYC) | 0.3 | $2.4M | 251k | 9.47 | |
| Deciphera Pharmaceuticals (DCPH) | 0.3 | $2.4M | 115k | 20.99 | |
| Translate Bio | 0.3 | $2.3M | 309k | 7.50 | |
| Vistagen Therapeutics | 0.2 | $2.2M | 1.5M | 1.50 | |
| Kornit Digital (KRNT) | 0.2 | $2.1M | 30k | 69.94 | |
| Arya Sciences Acquisition-a shs cl a | 0.2 | $2.0M | 200k | 10.24 | |
| Abeona Therapeutics | 0.2 | $1.9M | 270k | 7.14 | |
| Aerpio Pharmaceuticals | 0.2 | $1.9M | 1.1M | 1.70 | |
| Zafgen | 0.2 | $1.9M | 380k | 4.95 | |
| Pieris Pharmaceuticals (PIRS) | 0.2 | $1.9M | 700k | 2.66 | |
| Allena Pharmaceuticals | 0.2 | $1.9M | 345k | 5.45 | |
| Array BioPharma | 0.2 | $1.8M | 125k | 14.25 | |
| Molecular Templates | 0.2 | $1.6M | 400k | 4.04 | |
| Apellis Pharmaceuticals (APLS) | 0.2 | $1.5M | 117k | 13.19 | |
| Dova Pharmaceuticals | 0.2 | $1.4M | 185k | 7.58 | |
| Urovant Sciences | 0.2 | $1.4M | 214k | 6.59 | |
| Clearside Biomedical (CLSD) | 0.1 | $1.3M | 1.2M | 1.07 | |
| Melinta Therapeutics | 0.1 | $1.3M | 1.6M | 0.79 | |
| Nice Ltd convertible security | 0.1 | $1.3M | 250k | 5.14 | |
| Idera Pharmaceuticals | 0.1 | $1.2M | 446k | 2.77 | |
| Corvus Pharmaceuticals (CRVS) | 0.1 | $1.2M | 321k | 3.67 | |
| Savara (SVRA) | 0.1 | $833k | 110k | 7.57 | |
| Erytech Pharma Sa | 0.1 | $796k | 120k | 6.63 | |
| Verrica Pharmaceuticals (VRCA) | 0.1 | $791k | 97k | 8.15 | |
| Meiragtx Holdings (MGTX) | 0.1 | $686k | 71k | 9.64 | |
| Spring Bk Pharmaceuticals In | 0.1 | $530k | 51k | 10.39 | |
| Kezar Life Sciences (KZR) | 0.1 | $472k | 20k | 23.60 | |
| Sierra Oncology | 0.0 | $341k | 259k | 1.32 | |
| Cue Biopharma (CUE) | 0.0 | $235k | 50k | 4.70 | |
| Constellation Pharmceticls I | 0.0 | $281k | 70k | 4.01 | |
| Benitec Biopharma Ltd spons | 0.0 | $180k | 120k | 1.50 | |
| Adverum Biotechnologies | 0.0 | $200k | 63k | 3.16 | |
| Cellectar Biosciences | 0.0 | $136k | 88k | 1.55 |
